Search clinical trials for: PF-07038124 0.01% topical ointment

Total 200 results

Pfizer

Completed

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Plaque Psoriasis | Atopic Dermatitis

United States, Canada, United Kingdom, Japan
University of Colorado, Denver
Pfizer

Active, not recruiting

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

Vitiligo

United States
Pfizer

Completed

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis (EMPORIA)

Plaque Psoriasis | Atopic Dermatitis

United States, Australia, Canada, Poland
Icahn School of Medicine at Mount Sinai
Pfizer

Recruiting

PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea

Seborrheic Dermatitis | Papulopustular Rosacea

United States
Pfizer

Completed

A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants

Dermatitis Atopic

United States
Pfizer

Completed

Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants

Healthy

Japan
Abramson Cancer Center of the University of Pennsylvania

Completed

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

Cutaneous T Cell Lymphoma

United States
Pfizer

Completed

Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis

Dermatitis, Atopic

Australia, United States
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Meibomian Gland Dysfunction | MGD-Meibomian Gland Dysfunction

United States
Technoderma Medicines Inc.
Therapeutics, Inc.

Recruiting

Study of TDM-180935 in Atopic Dermatitis Patients

Atopic Dermatitis

United States
Tufts Medical Center
Pfizer

Withdrawn

Topical Crisaborole in Patients With Alopecia Areata

Alopecia Areata

United States
Bayer

Terminated

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Psoriasis

Germany
TWi Biotechnology, Inc.

Terminated

A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid

Bullous Pemphigoid

Taiwan
Pfizer

Completed

Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis

Dermatitis, Atopic

United States
BioGaia AB

Completed

Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis

Atopic Dermatitis

South Africa
Vidac Pharma
PharPoint Research, Inc.; Therapeutics, Inc.; Medistat Ltd., Israel

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis (Phase2b)

Actinic Keratosis

United States
Ahram Canadian University

Terminated

Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

Chronic Atopic Dermatitis

Egypt
Dermavant Sciences GmbH

Unknown

Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

United States
The University of Texas Health Science Center at...
National Institute on Aging (NIA)

Completed

Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock (Topical-RAPA)

Aging | Epigenetics | Inflammatory Mediators

United States
Peplin

Completed

Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design

Healthy

United States
Medimetriks Pharmaceuticals, Inc

Completed

Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis

Atopic Dermatitis

United States, Honduras, Panama
Pfizer

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic

United States
Pfizer

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic

United States
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males (TreatAIN)

High-grade Anal Intraepithelial Neoplasia
Vidac Pharma

Completed

Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Seton Healthcare Family

Completed

Topical Steroid Formulation and Wet Wraps

Dermatitis, Atopic

United States
Hoth Therapeutics, Inc.
Worldwide Clinical Trials

Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (CLEER)

Acneiform Eruption Due to Chemical | Xerosis Cutis | Paronychia

United States
Patel, Rita Vikram, M.D.

Completed

Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis (Tachyphylaxis)

Psoriasis
Azura Ophthalmics
Avania

Completed

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

Meibomian Gland Dysfunction

Australia, New Zealand
Integra LifeSciences Corporation
Integrium

Terminated

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use (STRIDE 5)

Diabetic Foot Ulcer

United States
Centre Hospitalier Universitaire de Nice

Completed

Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma (PICABAS)

Carcinoma

France
University of British Columbia

Unknown

Tacrolimus for Malar Edema

Edema Face

Canada
Azura Ophthalmics
The University of New South Wales

Completed

Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)

Meibomian Gland Dysfunction

Australia
Azura Ophthalmics
Avania

Completed

Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)

Contact Lens Discomfort

Australia
Azura Ophthalmics
ORA, Inc.

Not yet recruiting

A Phase 3 Study to Evaluate AZR-MD-001 in Patients With Abnormal Meibomian Gland Function and Dry Eye Disease (DED)

Dry Eye Disease

United States
Austin Institute for Clinical Research
OrthoDermatologics

Recruiting

Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

Plaque Psoriasis

United States
Jordan University of Science and Technology

Completed

Effects of Argan Spinosa Oil in the Treatment of Diaper Dermatitis in Infants and Toddlers

Diaper Rash

Jordan
Northwestern University

Terminated

Molecular Effects of Topical Calcipotriene on Morphea

Morphea | Localized Scleroderma

United States
Odense University Hospital

Completed

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

Breast Cancer Lymphedema

Denmark
Mahidol University

Completed

Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails

Psoriatic Nails

Thailand
Chang Gung Memorial Hospital
Ministry of Science and Technology, Taiwan

Completed

Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis

Atopic Dermatitis

Taiwan
Pfizer

Completed

A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

Healthy

United States
Massachusetts General Hospital

Terminated

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Breast Cancer

United States
Astellas Pharma Inc

Completed

Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

Atopic Dermatitis

Australia, Belgium, Poland, Hungary, Portugal, Germany, Iceland, Malta
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

Atopic Dermatitis

United States
Pelage Pharmaceuticals, Inc.

Not yet recruiting

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Androgenetic Alopecia
Pfizer

Completed

Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001

Reduction in Severity of Skin Scarring

United States
Rochester Skin Lymphoma Medical Group, PLLC
Rochester General Hospital

Completed

Mechlorethamine Induced Contact Dermatitis Avoidance Study (MIDAS)

Mycosis Fungoides | Cutaneous T-cell Lymphoma | Transformed Mycosis Fungoides | Cutaneous T-cell Lymphoma Stage I | Folliculotropic Mycosis Fungoides | Granulomatous Slack Skin | Syringotropic Mycosis Fungoides | Mycosis Fungoides Variant

United States
Mansoura University

Recruiting

Treatment Of Oral Lichen Planus

Lichen Planus

Egypt
Pfizer

Completed

A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

Psoriasis

Germany

3

Subscribe